about
sameAs
Explicit and implicit emotional expression in bulimia nervosa in the acute state and after recovery.Complete heart block in an adult with systemic lupus erythematosus and recent onset of hydroxychloroquine therapy.Prognostic value of NT-proBNP and an adapted monin score in patients with asymptomatic aortic stenosis.The effect of intravenous ferric carboxymaltose on health-related quality of life in patients with chronic heart failure and iron deficiency: a subanalysis of the FAIR-HF study.Iron deficiency is a key determinant of health-related quality of life in patients with chronic heart failure regardless of anaemia status.Iron deficiency and anaemia in heart failure: understanding the FAIR-HF trial.Repetitive use of levosimendan for treatment of chronic advanced heart failure: clinical evidence, practical considerations, and perspectives: an expert panel consensus.Efficacy of an integrated hospital-primary care program for heart failure: a population-based analysis of 56,742 patients.A pilot evaluation of the long-term effect of combined therapy with intravenous iron sucrose and erythropoietin in elderly patients with advanced chronic heart failure and cardio-renal anemia syndrome: influence on neurohormonal activation and cliniEffect of carvedilol therapy on functional mitral regurgitation, ventricular remodeling, and contractility in patients with heart failure due to left ventricular systolic dysfunction.Determinants of quality of life of patients with heart failure and iron deficiency treated with ferric carboxymaltose: FAIR-HF sub-analysis.Rapid point-of-care NT-proBNP optimal cut-off point for heart failure diagnosis in primary care.Survival in Mediterranean ambulatory patients with chronic heart failure. A population-based study.Health care and nonhealth care costs in the treatment of patients with symptomatic chronic heart failure in Spain.Trends and predictors of hospitalization, readmissions and length of stay in ambulatory patients with heart failure.Iron deficiency in chronic heart failure: an international pooled analysis.Iron deficiency and health-related quality of life in chronic heart failure: results from a multicenter European study.Validation of the Spanish version of the Kansas city cardiomyopathy questionnaire.Prescription in patients with chronic heart failure and multimorbidity attended in primary care.Associations between self-reported periodontal disease, assessed using a very short questionnaire, cardiovascular disease events and all-cause mortality in a contemporary multi-ethnic population: The Multi-Ethnic Study of Atherosclerosis (MESA)[Severe digoxin poisoning. The successful use of the classic treatment]Clinical predictors of outcome in patients with heart failure and neurohormonal blockade: referral for transplantation from heart failure units without heart transplantation programsCurrent situation of management of systolic heart failure in Spain: VIDA-IC study resultsDifferences in neurohormonal activity partially explain the obesity paradox in patients with heart failure: The role of sympathetic activationShort length of hospitalization in patients with acute heart failure entails a high risk of readmission: True or false? Insights from the LOHRCA studyPerformance of Comprehensive Risk Adjustment for the Prediction of In-Hospital Events Using Administrative Healthcare Data: The Queralt IndicesIron Deficiency: Impact on Functional Capacity and Quality of Life in Heart Failure with Preserved Ejection FractionValidation of the Spanish version of the questionnaire on Patient Empowerment in Long-Term Conditions
P50
Q30435233-2C5DB21A-A1E1-492C-9A94-0124649E4199Q32175872-257D3900-0C4D-407A-9656-513C3ABFD5ADQ33164211-5278D3F8-EB63-4B11-97F7-B1191016BDA6Q36499172-BD8289E7-0337-475A-93F8-CC6A998215ECQ37195233-DC9B0A45-1DF1-4CE6-813F-FDEC6DA07C6DQ37790519-50B10F58-BB9C-4F72-A7C4-0B5ABABE8191Q38208139-0B9970E8-4AAA-4C30-A6A1-AF60C4D10940Q40187361-97BC874F-8211-424B-8CCE-39FCBDF88831Q43251368-59F3525B-B302-41CB-B0D5-83DD6F175187Q43963090-4926590E-4310-490A-81EC-D126D98C9FC7Q44086478-12DBF6A3-EA5B-4444-AFE6-2EB1BCADC1D1Q44122782-0B5CF15C-6FAE-44A6-B861-303AEC7AEAF1Q44232735-6F33F861-7986-4B39-841B-EAF6A51CAA47Q44650102-253ED0D8-0496-46CB-AFF1-5422DD65DBBBQ44929716-A3624079-8300-40A1-93F9-28341C45D736Q46257022-BB4878D7-2432-4D50-A203-AA18F4C5F84AQ48078246-2CF6AA4C-521F-49DD-8DCC-3254546E3BBEQ48716418-9A957652-193F-43F7-A711-D9A97975C137Q50485764-9E16B397-7459-4E53-9333-0D2E47D06CC0Q57153617-42A66128-F153-4584-BDED-4F40B71489AAQ73538132-27DA1A69-7A59-4337-91FE-4625AB8C1576Q78693407-F80DD6DE-1F9B-48AD-9D0C-594C4B518463Q85216492-9AFF7D79-078C-4E0D-AE89-D5DA50B460AFQ86252998-EE6AC920-E7EC-468F-85C3-69D23ADF6CEEQ91077232-FBF05AF5-4128-4B8B-A220-2916677BFE05Q91840364-7C7DE0C6-BBA6-4B27-8F67-129DA45B805DQ93211463-7706645C-59F8-4712-AEA8-4A55D13930A8Q96341883-1DD387A2-01C2-41F8-B615-AD103BCC19E9
P50
description
researcher ORCID ID = 0000-0001-8780-720X
@en
wetenschapper
@nl
name
Josep Comín-Colet
@ast
Josep Comín-Colet
@en
Josep Comín-Colet
@nl
type
label
Josep Comín-Colet
@ast
Josep Comín-Colet
@en
Josep Comín-Colet
@nl
altLabel
Josep Comin-Colet
@en
Josep Comin-Colet
@nl
prefLabel
Josep Comín-Colet
@ast
Josep Comín-Colet
@en
Josep Comín-Colet
@nl
P106
P21
P31
P496
0000-0001-8780-720X